VC-backed cell therapy AlloVir goes public
AlloVir Inc, a cell therapy company, has raised $276.25 million for its IPO after pricing its 16.25 million shares at $17 per share.
AlloVir Inc, a cell therapy company, has raised $276.25 million for its IPO after pricing its 16.25 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination